Purpose. It is well known that acute exposure to high concentrations o
f glutamate is toxic to central mammalian neurons. However, the effect
of a chronic, minor elevation over endogenous glutamate levels has no
t been explored. The authors have suggested that such chronic exposure
may play a role in glaucomatous neuronal loss. In the current study,
they sought to explore whether a chronic, low-dose elevation in vitrea
l glutamate was toxic to retinal ganglion cells and whether this toxic
ity could be prevented with memantine, a glutamate antagonist. Methods
. Rats were injected serially and intravitreally with glutamate to ind
uce chronic elevations in glutamate concentration. A second group of r
ats was treated with intraperitoneal memantine and glutamate. Control
groups received vehicle injection with or without concurrent memantine
therapy. After 3 months, the animals were killed, and ganglion cell s
urvival was evaluated, Results. Intravitreal injections raised the int
ravitreal glutamate levels from an endogenous range of 5 to 12 mu M gl
utamate to 26 to 34 mu M. This chronic glutamate elevation killed 42%
of the retinal ganglion cells after 3 months. Memantine treatment alon
e had no effect on ganglion cell survival. However, when memantine was
given concurrently with low-dose glutamate, memantine was partially p
rotective against glutamate toxicity. Conclusions. These data suggest
that minor elevations in glutamate concentration can be toxic to gangl
ion cells if this elevation is maintained for 3 months. Furthermore, m
emantine is efficacious at protecting ganglion cells from chronic low-
dose glutamate toxicity.